TB-500 vs GHK-Cu is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
TB-500 and GHK-Cu are both popular research peptides that work through different mechanisms. TB-500 is a 43-amino acid peptide focused on wound healing, while GHK-Cu is a Tripeptide-copper complex targeting skin rejuvenation.
What Are TB-500 and GHK-Cu?
TB-500 (Thymosin Beta-4 Fragment (TB-500)) is a 43-amino acid peptide. Naturally occurring peptide present in virtually all human and animal cells. It is researched for wound healing, tissue repair, inflammation reduction, hair regrowth, cardiac repair, flexibility improvement.
GHK-Cu (GHK-Cu (Copper Peptide)) is a Tripeptide-copper complex. Naturally occurring peptide found in human plasma, saliva, and urine; levels decline significantly with age from 200 ng/mL at age 20 to 80 ng/mL by age 60. It is researched for skin rejuvenation, wound healing, anti-aging, hair growth, collagen production, anti-inflammatory effects.
While both are popular research peptides, they work through fundamentally different mechanisms and serve different primary purposes.
How Do TB-500 and GHK-Cu Work Differently?
TB-500 mechanism: TB-500 promotes cell migration by upregulating actin, a cell-building protein essential for cytoskeletal dynamics. It sequesters actin monomers to regulate polymerization, reduces inflammation by downregulating pro-inflammatory cytokines, and promotes angiogenesis and stem cell differentiation for tissue repair.
GHK-Cu mechanism: GHK-Cu modulates expression of over 4,000 human genes — activating those involved in tissue remodeling, antioxidant defense, and stem cell biology while suppressing genes associated with inflammation and tissue destruction. It promotes collagen and elastin synthesis, attracts immune cells to injury sites, and supports angiogenesis through metalloproteinase regulation.
These distinct mechanisms are why the two peptides are often used for different research goals — or combined to target multiple pathways.
How Do the Dosing Protocols Compare?
TB-500: 2-5 mg (loading), 2 mg (maintenance) administered 2x weekly (loading phase), weekly (maintenance) via subcutaneous or intramuscular injection. Half-life: approximately 2-3 hours. Cycle: 4-6 weeks loading, then ongoing maintenance.
GHK-Cu: 1-3 mg (injectable), topical formulations vary administered once daily via subcutaneous injection or topical application. Half-life: approximately 2-4 hours. Cycle: 4-12 weeks.
Use our peptide calculator for reconstitution math for either compound.
How Do the Benefits Compare?
TB-500 benefits: wound healing, tissue repair, inflammation reduction, hair regrowth, cardiac repair, flexibility improvement.
GHK-Cu benefits: skin rejuvenation, wound healing, anti-aging, hair growth, collagen production, anti-inflammatory effects.
The overlap in benefits determines whether these peptides compete for the same use case or complement each other in a stack.
How Do the Side Effects Compare?
TB-500: Generally well-tolerated. Temporary lethargy, head rush, or mild headache reported in some users. Minor injection site irritation possible. No organ toxicity documented in research.
GHK-Cu: Well-tolerated in research and cosmetic use. Mild injection site reactions possible. Topical use may cause temporary skin redness in sensitive individuals. No systemic toxicity reported.
Can You Stack TB-500 and GHK-Cu Together?
Many researchers combine TB-500 and GHK-Cu in stacking protocols. The different mechanisms mean they can potentially provide complementary effects without competing for the same receptors.
Pairs powerfully with BPC-157 in the 'Wolverine Stack' — TB-500 handles systemic inflammation and cardiac repair while BPC-157 targets gut and connective tissue. Also stacks well with GHK-Cu for skin and wound healing. See our stacking guide for general principles.
Which Is Better: TB-500 or GHK-Cu?
There is no universal answer. TB-500 may be preferable for researchers focused on wound healing, while GHK-Cu is stronger for skin rejuvenation.
For the most comprehensive results, many researchers combine both. Review each compound's individual guide for detailed protocols: TB-500 | GHK-Cu.
Complete Guide
TB-500 : Thymosin Beta-4, Research Evidence & Protocols
Research-Grade Sourcing
If you're going to research TB-500 vs GHK-Cu, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is TB-500 vs GHK-Cu?
TB-500 vs GHK-Cu (TB-500 vs GHK-Cu) is a research peptide. Synthetic peptide. It is researched for various applications.
What is the recommended TB-500 vs GHK-Cu dosage?
Common dosages: varies administered per protocol via subcutaneous injection. Cycle length: 4-12 weeks. Half-life: varies. Use our peptide calculator for exact reconstitution math.
What are the side effects of TB-500 vs GHK-Cu?
Limited safety data available. Potential injection site reactions and individual sensitivity. No serious adverse events documented in available literature.
Is TB-500 vs GHK-Cu safe?
TB-500 vs GHK-Cu has shown a preliminary safety profile in research. Not FDA-approved. Available as a research chemical in most jurisdictions. All research should follow appropriate safety protocols.